EDGAR Filing Documents for 0001193125-15-323029

Form CORRESP - Correspondence:

SEC Accession No. 0001193125-15-323029

Filing Date

2015-09-18

Accepted

2015-09-18 10:08:02

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.htm	CORRESP	943143
2	GRAPHIC	g948537g19x76.jpg	GRAPHIC	55031
3	GRAPHIC	g948537g23a67.jpg	GRAPHIC	144644
4	GRAPHIC	g948537g35z34.jpg	GRAPHIC	79377
5	GRAPHIC	g948537g39u76.jpg	GRAPHIC	128065
6	GRAPHIC	g948537g63z23.jpg	GRAPHIC	52890
7	GRAPHIC	g948537g66q00.jpg	GRAPHIC	70543
8	GRAPHIC	g948537g87w11.jpg	GRAPHIC	67476
9	GRAPHIC	g948537g98i73.jpg	GRAPHIC	3342
	Complete submission text file	0001193125-15-323029.txt		1772861

Mailing Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080

Business Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080 650.515.3185

CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations